NAVI
54
4
IP
14
-3
KMI
55
2
COF
50
-3
LNC
42
-3
HIG
68
-2
ED
59
11
ORLY
64
4
AAL
52
2
PBI
53
-3
DE
56
-2
HRL
36
10
ORCL
56
2
VRTX
55
2
SIG
17
-15
SLB
66
-4
GME
33
-21
DD
49
-3
PFE
25
-5
REGN
51
3
NAVI
54
4
IP
14
-3
KMI
55
2
COF
50
-3
LNC
42
-3
HIG
68
-2
ED
59
11
ORLY
64
4
AAL
52
2
PBI
53
-3
DE
56
-2
HRL
36
10
ORCL
56
2
VRTX
55
2
SIG
17
-15
SLB
66
-4
GME
33
-21
DD
49
-3
PFE
25
-5
REGN
51
3
Financhill
Back

US Physical Therapy 10K Form

Sell
40

USPH
US Physical Therapy

Last Price:
110.03
Seasonality Move:
3.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive USPH News And Ratings

See the #1 stock for the next 7 days that we like better than USPH

USPH Financial Statistics

Sales & Book Value

Annual Sales: $553.14M
Cash Flow: $9.29M
Price / Cash Flow: 28.24
Annual Sales: $24.35
Price / Book: 4.5

Profitability

EPS (TTM): 2.16000
Net Income (TTM): $27.21M
Gross Margin: $112.02M
Return on Equity: 8.72%
Return on Assets: 3.33%

US Physical Therapy Earnings Forecast

Key US Physical Therapy Financial Ratios

  • The Gross Profit Margin over the past 32 years for USPH is 20.25%.
  • The Selling, General & Administrative Expenses for USPH have been equal to 8.34% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 20.45% of Operating Income.
  • The Net Earning history of USPH is 5.11% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 17 years.

US Physical Therapy Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Medical Care Facilities
Sector: Healthcare
Current Symbol: USPH
CUSIP: 90337L
Website: usph.com

Debt

Debt-to-Equity Ratio: 0.6
Current Ratio: 1.3
Quick Ratio: 1.18

Price-to-Earnings

Trailing P/E Ratio: 48.69
Forward P/E Ratio: 34.92

USPH Technical Analysis vs Fundamental Analysis

Sell
40
US Physical Therapy (USPH) is a Sell

Is US Physical Therapy a Buy or a Sell?